ALK c.1999_2001delinsAGC ;(p.G667S)

Variant ID: 2-29498005-CCC-GCT

NM_004304.4(ALK):c.1999_2001delinsAGC;(p.G667S)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer.

Pharmaceutics
Leone, Gian Marco GM; Candido, Saverio S; Lavoro, Alessandro A; Vivarelli, Silvia S; Gattuso, Giuseppe G; Calina, Daniela D; Libra, Massimo M; Falzone, Luca L
Publication Date: 2023-04-16

Variant appearance in text: ALK: G667S
PubMed Link: 37111737
Variant Present in the following documents:
  • Main text
  • pharmaceutics-15-01252.pdf
View BVdb publication page



The Genomic Landscape of Actinic Keratosis.

The Journal Of Investigative Dermatology
Thomson, Jason J; Bewicke-Copley, Findlay F; Anene, Chinedu Anthony CA; Gulati, Abha A; Nagano, Ai A; Purdie, Karin K; Inman, Gareth J GJ; Proby, Charlotte M CM; Leigh, Irene M IM; Harwood, Catherine A CA; Wang, Jun J
Publication Date: 2021-07

Variant appearance in text: ALK: G667S
PubMed Link: 33482222
Variant Present in the following documents:
  • mmc1.xlsx, sheet 4
View BVdb publication page



Tyrosine Kinase Receptors in Oncology.

International Journal Of Molecular Sciences
Esteban-Villarrubia, Jorge J; Soto-Castillo, Juan José JJ; Pozas, Javier J; San Román-Gil, María M; Orejana-Martín, Inmaculada I; Torres-Jiménez, Javier J; Carrato, Alfredo A; Alonso-Gordoa, Teresa T; Molina-Cerrillo, Javier J
Publication Date: 2020-11-12

Variant appearance in text: ALK: G667S
PubMed Link: 33198314
Variant Present in the following documents:
  • ijms-21-08529.pdf
View BVdb publication page